Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

48.74
+1.092.29%
Post-market: 48.740.00000.00%17:27 EDT
Volume:1.42M
Turnover:69.00M
Market Cap:3.86B
PE:6.49
High:49.02
Open:48.35
Low:47.52
Close:47.65
Loading ...
OverviewCompanyNewsFilings

Concept

no data

No relevant data is available

Capital Flow

 
Inflow:
 
Outflow:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

News

Leerink Partners Sticks to Their Hold Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
02 Jul

BRIEF-Sephience™ (Sepiapterin) Granted Marketing Authorization By The European Commission

Reuters
·
23 Jun

PTC Therapeutics Secures European Commission Approval for Sephience™ to Treat Phenylketonuria in All Ages and Severities

Reuters
·
23 Jun

Sephience™ (Sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living With Phenylketonuria (Pku)

THOMSON REUTERS
·
23 Jun

Analyst Rate

Buy
Buy
64.71%
Hold
29.41%
Sell
5.88%

Corporate Actions

Financial Report Announcement
May 06, 2025 Post Market
Financial Report Announcement
Feb 27, 2025 Post Market
Financial Report Announcement
Nov 07, 2024 Post Market
Financial Report Announcement
Aug 08, 2024 Post Market
Financial Report Announcement
Apr 25, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

6.39
Current
-5.92
Sector Average
97.97%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
6.39
Maximum
6.89
+1 STD
-2.80
Minimum
-12.48
-1 STD
-9.04
Average
-5.92

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.